Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SSRI neonatal effects

Executive Summary

FDA Pediatric Subcommittee will consider effects of selective serotonin reuptake inhibitors on newborns following maternal use on June 9. The subcommittee will also hear adverse event reports for eight drugs, including Wyeth's Effexor and Aventis' Allegra. Pediatric research issues are also on the agenda. The meeting will be held at 5630 Fishers Lane in Rockville, Md. at 8 a.m. [To 1watch a webcast of an advisory committee meeting, go to FDAAdvisoryCommittee.com.]...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS043839

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel